Advamab 100 mg Injection

Advamab 100 mg Injection contains bevacizumab, an anticancer medicine used for the treatment of certain cancers. It is supplied as a 100 mg/4 mL formulation for intravenous infusion. The medicine helps inhibit the formation of new blood vessels that can support tumor growth.

BUY NOW

Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor involved in tumor angiogenesis. By blocking this pathway, it can help reduce the blood supply that supports cancer growth. Advamab may be used in prescribed treatment regimens for cancers such as colorectal, lung, kidney, ovarian, cervical, and certain brain cancers. Administration and monitoring should be managed by qualified healthcare professionals according to the oncology treatment protocol.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 100 mg/4 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 4 mL

Product Also Known As

Advamab 100 mg Injection, Bevacizumab 100 mg Injection, Advamab 100 mg/4 mL Injection, Bevacizumab Solution for Infusion, Advamab Cancer Injection, Bevacizumab Anticancer Injection